Expression and Clinical Significance of Wnt Players and Survivin in Pituitary Tumours
- 12 February 2012
- journal article
- Published by Springer Nature in Endocrine Pathology
- Vol. 23 (2) , 123-131
Abstract
Deregulation of the Wnt pathway has been implicated in oncogenesis of numerous tissues including the pituitary gland. Immunohistochemical localization and quantification of β-catenin, Cyclin D1, c-MYC and Survivin expression in 47 pituitary adenomas (35 non-functioning, seven GH-secreting, three prolactinomas, two ACTH-secreting tumour) and six normal controls was undertaken in this study and correlation of protein expression to patient and tumour characteristics analysed. β-catenin was strictly membrane-bound with no difference observed between normal and tumour tissue. In contrast, Cyclin D1 and c-MYC localization was nuclear and significantly higher in tumour versus normal tissue (p < 0.05). c-MYC expression correlated negatively with age at diagnosis (p = 0.006, R = −0.395) while Cyclin D1 expression correlated positively with age (p = 0.036, R = 0.306) and was higher in males than in females (p = 0.036). c-MYC expression was significantly lower in patients with functional tumours requiring octreotide treatment and in patients with non-functioning tumours suffering from hypopituitarism. Survivin expression was extremely low in tumours and absent in normal controls. Involvement of the canonical Wnt pathway appears to be minimal, given the segregation of β-catenin to the membrane. Our data suggest that c-MYC may have an important role in early pituitary tumorigenesis while Cyclin D1 is likely to promote tumour growth at a later stage. We also report a novel gender difference in Cyclin D1 expression, the biological significance of which merits further analysis. The reported reduction of c-MYC in functional tumours subsequently treated with octreotide further supports a role of c-MYC in early tumorigenesis and not in recurrence. The decrease in c-MYC in patients with hypopituitarism provides the first in vivo evidence for hormonal regulation of c-MYC expression.Keywords
This publication has 60 references indexed in Scilit:
- Increased Wingless ( Wnt ) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humansProceedings of the National Academy of Sciences, 2011
- Developmental Control of Apoptosis by the Immunophilin Aryl Hydrocarbon Receptor-interacting Protein (AIP) Involves Mitochondrial Import of the Survivin ProteinJournal of Biological Chemistry, 2011
- Myc Oncogene-Induced Genomic Instability: DNA Palindromes in Bursal LymphomagenesisPLOS Genetics, 2008
- A Quiet Leader Unites Researchers in Drive for the Next Big MachineScience, 2006
- Predicting Therapeutic Response and Degree of Pituitary Tumour Shrinkage during Treatment of Acromegaly with Octreotide LARHormone Research in Paediatrics, 2004
- Expression of Survivin, a Novel Inhibitor of Apoptosis, in Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 2004
- Frequent nuclear accumulation of ?-catenin in pituitary adenomaCancer, 2001
- D-type cyclinsTrends in Biochemical Sciences, 1995
- Oncoprotein immunoreactivity in human pituitary tumoursClinical Endocrinology, 1994
- Hypothalamo-pituitary regulation of the c- myc gene in rat liverJournal of Molecular Endocrinology, 1990